• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在日本全科医生诊所中,临床症状评分对区分新型冠状病毒肺炎患者与普通感冒门诊患者的有效性。

Validity of Clinical Symptoms Score to Discriminate Patients with COVID-19 from Common Cold Out-Patients in General Practitioner Clinics in Japan.

作者信息

Sonoda Shiro, Kuramochi Jin, Matsuyama Yusuke, Miyazaki Yasunari, Fujiwara Takeo

机构信息

Kuramochi Clinic Interpark, Utsunomiya, Tochigi 321-0114, Japan.

Department of Global Health Promotion, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.

出版信息

J Clin Med. 2021 Feb 19;10(4):854. doi: 10.3390/jcm10040854.

DOI:10.3390/jcm10040854
PMID:33669685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7922190/
Abstract

OBJECTIVE

Coronavirus disease 2019 (COVID-19) has spread worldwide, including Japan. However, little is known about the clinical symptoms which discriminate between COVID-19 and non-COVID-19 among outpatients in general practitioner clinics, which is important for efficient case detection. The aim of this study was to investigate the clinical symptoms to discriminate between COVID-19 and non-COVID-19 cases among outpatients in general practitioner clinics during the second wave of the COVID-19 pandemic in Japan in August 2020.

METHODS

The records of 360 patients who visited a clinic with suspicion of infectious disease and underwent COVID-19 PCR test between 1 and 14 August 2020 were used. The patients filled out a questionnaire on possible clinical symptoms and transmission routes. Multivariate logistic regression was used to investigate the association between clinical symptoms and COVID-19 status.

RESULTS

COVID-19-positive patients were 17 (4.7%). Multiple logistic regression analyses showed that anosmia (odds ratio (OR), 25.94 95% confidence interval (CI), 7.15-94.14; < 0.001), headache (OR, 3.31 95% confidence interval (CI), 0.98-11.20; = 0.054), sputum production (OR, 3.32 CI, 1.01-10.90; = 0.048) and history of visiting an izakaya or bar (OR, 4.23 CI, 0.99-18.03; = 0.051) were marginally significantly associated withbeing COVID-19 positive. This model showed moderate predictive power (area under receiver operating characteristic curve = 0.870 CI, 0.761 to 0.971).

CONCLUSIONS

We found that anosmia, headache, sputum production, history of visiting an izakaya or bar were associated with COVID-19, which can be used to detect patients with COVID-19 in out-patient clinics in Japan. The findings of this study need to be verified in other clinics and hospitals in Japan and other countries with universal healthcare coverages.

摘要

目的

2019冠状病毒病(COVID-19)已在全球范围内传播,包括日本。然而,在全科诊所的门诊患者中,对于区分COVID-19和非COVID-19的临床症状知之甚少,而这对于高效病例检测很重要。本研究的目的是调查2020年8月日本COVID-19大流行第二波期间,全科诊所门诊患者中区分COVID-19和非COVID-19病例的临床症状。

方法

使用了2020年8月1日至14日期间因怀疑感染疾病就诊并接受COVID-19 PCR检测的360例患者的记录。患者填写了一份关于可能的临床症状和传播途径的问卷。采用多因素逻辑回归分析临床症状与COVID-19状态之间的关联。

结果

COVID-19阳性患者有17例(4.7%)。多因素逻辑回归分析显示,嗅觉丧失(优势比(OR),25.94;95%置信区间(CI),7.15 - 94.14;P < 0.001)、头痛(OR,3.31;95%置信区间(CI),0.98 - 11.20;P = 0.054)、咳痰(OR,3.32;CI,1.01 - 10.90;P = 0.048)以及去过居酒屋或酒吧的经历(OR,4.23;CI,0.99 - 18.03;P = 0.051)与COVID-19呈边缘显著相关。该模型显示出中等预测能力(受试者工作特征曲线下面积 = 0.870;CI,0.761至0.971)。

结论

我们发现嗅觉丧失、头痛、咳痰、去过居酒屋或酒吧的经历与COVID-19相关,可用于在日本的门诊诊所检测COVID-19患者。本研究结果需要在日本其他诊所和医院以及其他有全民医保覆盖的国家进行验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ed/7922190/8049c3b24e32/jcm-10-00854-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ed/7922190/8049c3b24e32/jcm-10-00854-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ed/7922190/8049c3b24e32/jcm-10-00854-g001.jpg

相似文献

1
Validity of Clinical Symptoms Score to Discriminate Patients with COVID-19 from Common Cold Out-Patients in General Practitioner Clinics in Japan.在日本全科医生诊所中,临床症状评分对区分新型冠状病毒肺炎患者与普通感冒门诊患者的有效性。
J Clin Med. 2021 Feb 19;10(4):854. doi: 10.3390/jcm10040854.
2
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗或医院门诊环境中,出现症状和体征来确定患者是否患有 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2.
4
Clinical decision support tool for diagnosis of COVID-19 in hospitals.临床决策支持工具,用于医院 COVID-19 诊断。
PLoS One. 2021 Mar 11;16(3):e0247773. doi: 10.1371/journal.pone.0247773. eCollection 2021.
5
Universal screening for SARS-CoV-2 infection: a rapid review.SARS-CoV-2 感染的普遍筛查:快速综述。
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.
6
A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.一项由日本综合传染病管理(IMJEDI 研究-RCT)开展的多中心、随机对照临床试验,评估了汉方药加味抗感煎剂(kakkonto with shosaikotokakikyosekko)在缓解 COVID-19 轻症和中度患者症状和预防重症方面的作用:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 2;21(1):827. doi: 10.1186/s13063-020-04746-9.
7
Clinical Characteristics of Japanese Patients Who Visited a COVID-19 Aftercare Clinic for Post-Acute Sequelae of COVID-19/Long COVID.因新冠后遗症/长期新冠前往新冠后护理诊所就诊的日本患者的临床特征
Cureus. 2021 Oct 7;13(10):e18568. doi: 10.7759/cureus.18568. eCollection 2021 Oct.
8
Time taken by individuals with respiratory symptoms to present to primary care: a descriptive study of assessments at Australian General Practitioner-led respiratory clinics.有呼吸道症状的患者前往基层医疗就诊的时间:对澳大利亚全科医生主导的呼吸道诊所评估的描述性研究。
Commun Dis Intell (2018). 2022 Apr 26;46. doi: 10.33321/cdi.2022.46.20.
9
SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan.日本综合医院和诊所医护人员中 SARS-CoV-2 的血清流行率。
Int J Environ Res Public Health. 2021 Apr 5;18(7):3786. doi: 10.3390/ijerph18073786.
10
Impact of state of emergency for coronavirus disease 2019 on hospital visits and disease exacerbation: the Japan COVID-19 and Society Internet Survey.2019年冠状病毒病紧急状态对医院就诊和疾病加重的影响:日本COVID-19与社会互联网调查
Fam Pract. 2022 Sep 24;39(5):883-890. doi: 10.1093/fampra/cmac016.

引用本文的文献

1
Clinical diagnosis of SARS-CoV-2 infection: An observational study of respiratory tract infection in primary care in the early phase of the pandemic.SARS-CoV-2 感染的临床诊断:大流行早期初级保健中呼吸道感染的观察性研究。
Eur J Gen Pract. 2023 Dec;29(1):2270707. doi: 10.1080/13814788.2023.2270707. Epub 2023 Oct 23.
2
Headache in Post-COVID-19 Patients: Its Characteristics and Relationship with the Quality of Life.新冠康复患者的头痛:其特征及其与生活质量的关系。
Medicina (Kaunas). 2022 Oct 21;58(10):1500. doi: 10.3390/medicina58101500.
3
SARS-CoV-2 suppression and early closure of bars and restaurants: a longitudinal natural experiment.

本文引用的文献

1
Vitamin D Status Is Associated With In-Hospital Mortality and Mechanical Ventilation: A Cohort of COVID-19 Hospitalized Patients.维生素 D 状况与住院死亡率和机械通气相关:一项 COVID-19 住院患者队列研究。
Mayo Clin Proc. 2021 Apr;96(4):875-886. doi: 10.1016/j.mayocp.2021.01.001. Epub 2021 Jan 9.
2
Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April 2020-a cross-sectional study.2020 年 3 月至 4 月德国柏林一个检测点的 SARS-CoV-2 感染的流行病学和临床特征:一项横断面研究。
Clin Microbiol Infect. 2020 Dec;26(12):1685.e7-1685.e12. doi: 10.1016/j.cmi.2020.08.017. Epub 2020 Aug 20.
3
SARS-CoV-2 抑制和酒吧、餐馆的早期关闭:一项纵向自然实验。
Sci Rep. 2022 Jul 23;12(1):12623. doi: 10.1038/s41598-022-16428-4.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Exploring the Clinical Utility of Gustatory Dysfunction (GD) as a Triage Symptom Prior to Reverse Transcription Polymerase Chain Reaction (RT-PCR) in the Diagnosis of COVID-19: A Meta-Analysis and Systematic Review.探索味觉功能障碍(GD)作为新冠病毒疾病(COVID-19)诊断中逆转录聚合酶链反应(RT-PCR)之前的分诊症状的临床效用:一项荟萃分析和系统评价。
Life (Basel). 2021 Nov 29;11(12):1315. doi: 10.3390/life11121315.
Inverted Covariate Effects for First versus Mutated Second Wave Covid-19: High Temperature Spread Biased for Young.
新冠疫情第一波与变异第二波中的反向协变量效应:高温传播对年轻人有偏向性。
Biology (Basel). 2020 Aug 14;9(8):226. doi: 10.3390/biology9080226.
4
A predictive score for COVID-19 diagnosis using clinical, laboratory and chest image data.基于临床、实验室和胸部影像数据的 COVID-19 诊断预测评分。
Braz J Infect Dis. 2020 Jul-Aug;24(4):343-348. doi: 10.1016/j.bjid.2020.06.009. Epub 2020 Jul 25.
5
Coronavirus Disease Exposure and Spread from Nightclubs, South Korea.韩国夜店的冠状病毒病暴露和传播。
Emerg Infect Dis. 2020 Oct;26(10):2499-2501. doi: 10.3201/eid2610.202573. Epub 2020 Jul 7.
6
A predictive model and scoring system combining clinical and CT characteristics for the diagnosis of COVID-19.一种结合临床和 CT 特征的 COVID-19 诊断预测模型和评分系统。
Eur Radiol. 2020 Dec;30(12):6797-6807. doi: 10.1007/s00330-020-07022-1. Epub 2020 Jul 1.
7
Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence.因冠状病毒病(COVID-19)引起的嗅觉和味觉障碍:当前证据综述。
Eur Arch Otorhinolaryngol. 2021 Feb;278(2):307-312. doi: 10.1007/s00405-020-06120-6. Epub 2020 Jun 17.
8
Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York.在纽约布朗克斯的 COVID-19 患者队列中,严重肥胖、年龄增长和男性性别与住院期间的不良结局独立相关,并与更高的住院死亡率相关。
Metabolism. 2020 Jul;108:154262. doi: 10.1016/j.metabol.2020.154262. Epub 2020 May 16.
9
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
10
CT differential diagnosis of COVID-19 and non-COVID-19 in symptomatic suspects: a practical scoring method.CT 鉴别诊断症状性疑似 COVID-19 与非 COVID-19:一种实用评分方法。
BMC Pulm Med. 2020 May 7;20(1):129. doi: 10.1186/s12890-020-1170-6.